Corbus Pharma (CRBP) Misses Q4 EPS by 4c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: CRBP) | Delayed: 3.69 -0.18 (4.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.87 | 52 Week High | $10.78 | |||
| Open | $3.97 | 52 Week Low | $1.01 | |||
| Day High | $4.10 | P/E | N/A | |||
| Day Low | $3.61 | EPS | $0.00 | |||
| Volume | 1,606,403 | |||||
